Evidence mapPaperPMID 41748294Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Organ-Specific Perfusion Response to Adenosine as Measured Using Total-Body PET.

Henri Kärpijoki, Jouni Tuisku, Santeri Palonen, Chunlei Han, Hidehiro Iida, Riku Klén, Vesa Oikonen, Jarmo Teuho, Antti Saraste, Lauri Nummenmaa and 3 more

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Henri KärpijokiTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland; hjkarp@utu.fi.
Jouni TuiskuTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Santeri PalonenTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Chunlei HanTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Hidehiro IidaTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Riku KlénTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Vesa OikonenTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Jarmo TeuhoTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Antti SarasteTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Lauri NummenmaaTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Sergey V NesterovTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Teemu MaaniittyTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.
Juhani KnuutiTurku PET Centre, Turku University Hospital, and University of Turku, Turku, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine is routinely used as a pharmacologic stressor in myocardial perfusion imaging, but its effects on other organs have not been comprehensively studied. The aim of this study was to investigate the effects of adenosine on the perfusion of different organs using a long-axial-field-of-view (LAFOV) PET scanner.

Indexed as

AdenosineOrgan SpecificityPositron-Emission TomographyWhole Body ImagingAgedCoronary Artery DiseaseFemaleHumansMaleMiddle AgedMyocardial Perfusion ImagingAdenosine[15O]H2OadenosineLAFOV PETmyocardial blood flow

Identifiers

PMID41748294
PMCPMC13321948

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.